Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,908,299
-
Share change
-
+9,788,228
-
Total reported value
-
$122,413,000
-
Price per share
-
$11.37
-
Number of holders
-
44
-
Value change
-
+$109,677,015
-
Number of buys
-
39
Institutional Holders of MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) as of Q4 2020
As of 31 Dec 2020,
MOONLAKE IMMUNOTHERAPEUTICS - COM (HLXA) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,908,299 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., WELLINGTON MANAGEMENT GROUP LLP, CITADEL ADVISORS LLC, Ghost Tree Capital, LLC, Cormorant Asset Management, LP, and Octagon Capital Advisors LP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.